These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 9624468
21. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin . Livermore DM, Seetulsingh P. J Antimicrob Chemother; 1991 Jun; 27(6):761-7. PubMed ID: 1669013 [Abstract] [Full Text] [Related]
22. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates. Totir MA, Padayatti PS, Helfand MS, Carey MP, Bonomo RA, Carey PR, van den Akker F. Biochemistry; 2006 Oct 03; 45(39):11895-904. PubMed ID: 17002290 [Abstract] [Full Text] [Related]
25. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital]. Bémer-Melchior P, Gilly L, Jugroot-Klotz K, Brun T, Névot P, Paul G. Pathol Biol (Paris); 1995 Nov 03; 43(9):760-5. PubMed ID: 8746097 [Abstract] [Full Text] [Related]
26. Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors. Vakulenko S, Golemi D. Antimicrob Agents Chemother; 2002 Mar 03; 46(3):646-53. PubMed ID: 11850243 [Abstract] [Full Text] [Related]
28. Substrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase. Papp-Wallace KM, Taracila M, Hornick JM, Hujer AM, Hujer KM, Distler AM, Endimiani A, Bonomo RA. Antimicrob Agents Chemother; 2010 Jul 03; 54(7):2867-77. PubMed ID: 20421396 [Abstract] [Full Text] [Related]
30. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases. Gatermann S, Marre R. Infection; 1991 Jul 03; 19(2):106-9. PubMed ID: 1646771 [Abstract] [Full Text] [Related]
31. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors. Tajada P, Gomez-Graces JL, Alós JI, Balas D, Cogollos R. Antimicrob Agents Chemother; 1996 Aug 03; 40(8):1924-5. PubMed ID: 8843305 [Abstract] [Full Text] [Related]
32. The asparagine to aspartic acid substitution at position 276 of TEM-35 and TEM-36 is involved in the beta-lactamase resistance to clavulanic acid. Saves I, Burlet-Schiltz O, Swarén P, Lefèvre F, Masson JM, Promé JC, Samama JP. J Biol Chem; 1995 Aug 04; 270(31):18240-5. PubMed ID: 7629142 [Abstract] [Full Text] [Related]
38. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains. Higgins PG, Wisplinghoff H, Stefanik D, Seifert H. Antimicrob Agents Chemother; 2004 May 04; 48(5):1586-92. PubMed ID: 15105109 [Abstract] [Full Text] [Related]